TCL Archive Adverse data from cancer prevention trial makes Merck withdraw Vioxx from market. Researchers discuss implications for other cancer prevention trials. October 15, 2004
TCL Archive Senate Report Calls on NCI To Expand Research in Survivorship, CAM, GYN Cancers, And Fund Five Pancreatic SPOREs August 2, 2002
TCL Archive “A significant reduction in the NCI IRP AIDS program may be in order, and released funds should … increase the pool available to extramural research.” July 21, 1995
